Table 2. Patient outcomes by cancer characteristics.
| Solid vs Liquid |
Liquid (n = 37) |
Solid (n = 209) |
Unadjusted | Adjusted† | ||
|---|---|---|---|---|---|---|
| Outcome | n (%) | n (%) | OR (95% CI) | p-value | OR (95% CI) | p-value |
| ICU | 8 (21.6%) | 40 (19.1%) | 0.86 (0.38–2.14) | 0.726 | 0.98 (0.43–2.46) | 0.958 |
| Intubated | 5 (13.5%) | 24 (11.5%) | 0.83 (0.32–2.6) | 0.724 | 1.22 (0.44–4.02) | 0.721 |
| Death | 12 (32.4%) | 50 (23.9%) | 0.66 (0.31–1.44) | 0.274 | 0.54 (0.23–1.3) | 0.157 |
| Death during hospitalization | 12 (32.4%) | 37 (17.7%) | 0.45 (0.21–1) | 0.042 | 0.51 (0.21–1.27) | 0.134 |
| Re-admission | 12 (32.4%) | 71 (34%) | 1.07 (0.52–2.33) | 0.855 | 1.1 (0.52–2.43) | 0.814 |
| Among solid tumors: metastatic vs not: |
Not metastatic (n = 160) |
Metastatic (n = 49) |
Unadjusted | Adjusted† | ||
|---|---|---|---|---|---|---|
| Outcome | n (%) | n (%) | OR (95% CI) | p-value | OR (95% CI) | p-value |
| ICU | 32 (20%) | 8 (16.3%) | 0.78 (0.31–1.76) | 0.568 | 0.69 (0.27–1.57) | 0.395 |
| Intubated | 19 (11.9%) | 5 (10.2%) | 0.84 (0.27–2.24) | 0.748 | 0.93 (0.28–2.67) | 0.892 |
| Death | 35 (21.9%) | 15 (30.6%) | 1.58 (0.76–3.19) | 0.212 | 1.92 (0.83–4.38) | 0.1204 |
| Re-admission | 56 (35%) | 15 (30.6%) | 0.82 (0.4–1.61) | 0.571 | 0.78 (0.37–1.57) | 0.498 |
| Lung involvement vs not: |
No lung involvement (n = 176) |
Lung involvement (n = 33) |
Unadjusted | Adjusted† | ||
|---|---|---|---|---|---|---|
| Outcome | n (%) | n (%) | OR (95% CI) | p-value | OR (95% CI) | p-value |
| ICU | 31 (17.6%) | 9 (27.3%) | 1.75 (0.71–4.04) | 0.200 | 1.74 (0.7–4.03) | 0.212 |
| Intubated | 19 (10.8%) | 5 (15.2%) | 1.48 (0.46–4.03) | 0.474 | 2.01 (0.59–6.02) | 0.229 |
| Death | 38 (21.6%) | 12 (36.4%) | 2.08 (0.92–4.55) | 0.072 | 2.28 (0.91–5.63) | 0.074 |
| Re-admission | 59 (33.5%) | 12 (36.4%) | 1.13 (0.51–2.43) | 0.752 | 0.88 (0.37–1.96) | 0.751 |
| Receiving treatment vs not: |
Not receiving treatment (n = 204) |
Receiving treatment (n = 42) |
Unadjusted | Adjusted† | ||
|---|---|---|---|---|---|---|
| Outcome | n (%) | n (%) | OR (95% CI) | p-value | OR (95% CI) | p-value |
| ICU | 39 (19.1%) | 9 (21.4%) | 1.15 (0.49–2.52) | 0.731 | 0.95 (0.39–2.13) | 0.908 |
| Intubated | 24 (11.8%) | 5 (11.9%) | 1.01 (0.32–2.64) | 0.980 | 0.76 (0.23–2.08) | 0.613 |
| Death | 44 (21.6%) | 18 (42.9%) | 2.73 (1.35–5.47) | 0.005 | 4.45 (1.9–10.65) | 0.001 |
| Re-admission | 68 (33.3%) | 15 (35.7%) | 1.11 (0.54–2.2) | 0.766 | 0.95 (0.45–1.94) | 0.887 |
| Among those receiving treatment: cytotoxic vs other |
Other (n = 19) |
Cytotoxic (n = 23) |
Unadjusted | Adjusted† | ||
|---|---|---|---|---|---|---|
| Outcome | n (%) | n (%) | OR (95% CI) | p-value | OR (95% CI) | p-value |
| ICU | 6 (31.6%) | 3 (13%) | 0.33 (0.06–1.46) | 0.156 | 0.3 (0.06–1.39) | 0.138 |
| Intubated | 3 (15.8%) | 2 (8.7%) | 0.51 (0.06–3.41) | 0.486 | 0.43 (0.05–3.07) | 0.404 |
| Death | 9 (47.4%) | 9 (39.1%) | 0.71 (0.21–2.45) | 0.592 | 0.96 (0.22–4.2) | 0.952 |
| Re-admission | 6 (31.6%) | 9 (39.1%) | 1.39 (0.39–5.2) | 0.612 | 1.35 (0.37–5.12) | 0.647 |
†
See Table 3 listing covariates included in the adjusted model for each outcome.
ICU: Intensive care unit; OR: Odds ratio.